Jiangxi Rimag Group Co., Ltd. (HKG:2522)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Medical Labs & Research	760.59M	928.91M	784.44M	592.01M
Medical Labs & Research Growth	-18.12%	18.42%	32.50%	-
Total	760.59M	928.91M	784.44M	592.01M
Total Growth	-18.12%	18.42%	32.50%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
China	760.59M	928.91M	784.44M	592.01M
China Growth	-18.12%	18.42%	32.50%	-
Total	760.59M	928.91M	784.44M	592.01M
Total Growth	-18.12%	18.42%	32.50%	-

Source: S&P Global Market Intelligence.